Legislative Update:

This week, I was proud to attend the White House bill signing of the bipartisan HALT Fentanyl Act. This law will crack down on illicit fentanyl and fentanyl-related substances from making it into American communities and threatening the lives of American citizens. Too many Ohioans and their loved ones have been devastated by the opioid epidemic, especially the scourge of deadly fentanyl. By signing this law today, we mark a turning point in keeping fentanyl out of our communities and honor those we’ve needlessly lost.

Also this week, I reintroduced my bipartisan Patient Access to Innovative New Technologies (PAINT) Act with my colleague, Danny K. Davis (D-Ill.). Our legislation makes it easier for Medicare recipients to take advantage of the newest treatments without bureaucratic delay. This bipartisan bill would result in better health outcomes for our seniors and would help the system deliver care more efficiently and in line with its mission. I ask all my colleagues to join us in support of this commonsense legislation.

Social Media Update:

Crypto in Congress:

This week was crypto week in Congress, and we passed three pro-cryptocurrency bills through the House of Representatives, including the Guiding and Establishing National Innovation for U.S. Stablecoins (GENIUS) Act, Digital Asset Market Clarity (CLARITY) Act, and the Anti-CBDC Surveillance State Act. Every year, more Americans are adding digital assets to their portfolios and more businesses are preparing to innovate with cryptocurrency, and we are creating an environment for crypto to grow and thrive. Read more here.

On Wednesday in the Ways and Means Committee, we held a hearing on how we can set crypto up for a future of success in America. You can watch my questions for our expert witnesses by clicking here or on the image below.

Better Deals for American Patients:

This week, I joined a group of 33 lawmakers in a letter to U.S. Trade Representative (USTR) Jamieson Greer, urging further action to address foreign policy measures that force the American health care system to bear the burden of subsidizing pharmaceutical research and development (R&D) used across the world. The letter applauds the USTR’s recent Request for Comments Regarding Foreign Nations Freeloading on American-Financed Innovation, emphasizes the importance of global trading partners appropriately valuing U.S. medical innovation, and calls for an end to the practice of shifting R&D costs onto Americans. Read more here.

Staying in Touch:

It is a privilege to serve Ohio in Congress, and I want to make sure you can keep up with all the news here in Washington. If you haven’t already, follow me on X, Facebook, and YouTube for updates on my work for Ohio’s 15th District, visit my website to see what services my office offers, and please share this newsletter with a friend and encourage them to sign up here for regular updates. If you have a problem we can solve or a question you’d like answered, feel free to call my office at 202-225-2015 (Washington D.C.) or 614-927-6902 (Columbus).

Sincerely,